Related Experiment Video
Updated: Nov 15, 2025

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
Socioeconomic Impact of RSV Hospitalization
Michal Young1, Lynn Smitherman2
1Department of Pediatrics and Child Health, Howard University Hospital, Washington, DC, USA. m_a_young@Howard.edu.
Insights
Respiratory syncytial virus (RSV) causes significant illness and death in young children globally, particularly in developing nations. Identifying sociodemographic risk factors is crucial for managing severe RSV disease and its substantial healthcare burden.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Respiratory syncytial virus (RSV) infection is a leading cause of childhood illness and death worldwide, disproportionately affecting developing countries.
- Severe RSV disease, including lower respiratory tract infections (LRTI), leads to hospitalization, intensive care, and long-term health issues.
- Sociodemographic factors significantly influence the risk and severity of RSV disease in children.
Purpose of the Study:
- To review the socioeconomic impact and healthcare resource utilization associated with RSV-related hospitalizations (RSVH).
- To identify key sociodemographic risk factors for severe RSV disease in children.
- To inform the consideration of RSV prophylaxis strategies.
Main Methods:
- This review synthesizes existing literature on RSV disease burden, risk factors, and healthcare utilization.
- It examines data on hospitalization rates, intensive care admissions, and mortality.
- The review analyzes sociodemographic variables associated with severe RSV outcomes.
Main Results:
- RSV poses a substantial global health burden, with most severe cases and mortality occurring in developing countries.
- Independent risk factors for severe RSV include young age and premature birth.
- RSV hospitalizations result in significant healthcare resource utilization, long-term complications, and socioeconomic costs for families and healthcare systems.
Conclusions:
- Understanding sociodemographic risk factors is essential for identifying high-risk children for severe RSV disease.
- The significant morbidity, mortality, and socioeconomic impact of RSV underscore the need for effective prevention and management strategies.
- Current prophylaxis options like palivizumab are limited to specific high-risk groups, highlighting the need for broader interventions.
Abstract:
Respiratory syncytial virus (RSV) disease is a significant cause of morbidity and socioeconomic burden worldwide among young children. The majority of RSV-associated lower respiratory tract infections (LRTI) and mortality occurs in developing countries and is associated with various sociodemographic risk factors. Independent risk factors for severe RSV disease include age and premature birth. While RSV mortality in developed countries is lower relative to developing countries, high-risk infants with comorbidities experience higher rates of mortality. RSV LRTI is often severe and is associated with hospitalization, increased need for intensive care unit admission and mechanical ventilation, long-term complications, and caregiver stress and loss of work productivity. Overall, these factors translate to higher health care resource utilization and costs and should be factored into the consideration for RSV prophylaxis. Multiple vaccine candidates and long-acting monoclonal antibodies are in various stages of clinical development. Currently, palivizumab is the only approved RSV immunoprophylaxis available for use in specific high-risk pediatric populations. This review will discuss the socioeconomic impact and health care resource utilization of RSV-related hospitalization (RSVH) as well as various sociodemographic risk factors that can be used to identify children at high risk of developing severe RSV disease.
More Related Videos
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Relative Risk
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumonia III: Complications and Assessment
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pulmonary Cycle: Exhalation